CRISPR method efficiently corrects DMD defect in heart tissue – Drug Target Review
Drug Target Review |
CRISPR method efficiently corrects DMD defect in heart tissue
Drug Target Review Scientists have developed a CRISPR gene-editing technique that can potentially correct a majority of the 3,000 mutations that cause Duchenne muscular dystrophy (DMD) by making a single cut at strategic points along the patient's DNA, according to a … |
